CDKN2A and astrocytoma (excluding glioblastoma): CDKN2A/B (Cyclin Dependent Kinase Inhibitor) homozygous deletion emerges as an independent prognostic marker in all grades of IDH-mutant astrocytomas, including grade 4 astrocytoma.